The Medical Intelligence Unit
The Medical Intelligence Unit (MIU) is Alivia’s internal research team which is comprised of medical intelligence analysts, researchers, physicians and Ph.Ds.
The MIU’s primary role is to collect “medical intelligence” on a case by case basis that is relevant to our clients’ medical condition and use it to either improve the clients health regarding an existing condition or, after a medical screening has been sought; to help them be proactive and try to predict and prevent medical risk factors from materialising.
The MIU’s operations are managed by Dr. Tomas Norlindh, and Dr. Anastasia Malek, Ph.D., is responsible for its research activities. Drs. Malek and Norlindh report to Dr. Vidar Arnulf, our chief medical officer, who is responsible for all medical output.
The MIU’s purpose is to:
- Collect soft and hard medical intelligence regarding diseases, treatment options, doctors and hospitals from public and private sources
- Establish and maintain databases with information about these topics
- Produce timely analyses and reports that provide insight, warning and opportunity to our clients to pre-empt and/or contain disease and illness
Medical Intelligence Unit Research Sources
The in-depth research undertaken by the MIU on a case by case basis to search high and low for the best medical solutions includes the following:
- Medical Journals
- Alivia’s physician network
- Clinical Trials
- Doctor due intelligence
- Statistics about operations
- Hospital due diligence
- Patient reviews
- Treatment data results
- Conference participation
Meet the Senior Members of Alivia’s Medical Intelligence Unit team
Dr Vidar Arnulf, MD
Chief Medical Officer, Medical Intelligence Unit
Dr. Arnulf is a visionary and healthcare entrepreneur with more than 30 years’ leadership experience in the health care industry. He is a board certified anaesthesiologist and one of our principal founders. He played a key role in the creation of Alivia’s products and services.
Dr Tomas Norlindh, MD
Medical Director, Medical Intelligence Unit
Dr. Norlindh is the former Department Head of the Radiology and Nuclear Medicine Clinic at Spital Limmattal hospital in Zurich, Switzerland where he worked for more than 20 years. Dr. Norlindh also served as a member of the National Swiss board responsible for the postgraduate education of Swiss radiologists.
Prior to his position at Spital Limmattal, Dr. Norlindh served as a senior consultant to the Radiology Department at the Hospital of Winterthur, Switzerland. Dr. Norlindh is a member of the Swiss Society of Radiology, the Swedish Society of Radiology and the European Society of Radiology.
Dr. Norlindh received his medical degree from the University of Innsbruck, Austria. He speaks Swedish, German, Swiss-German and English.
Dr Anastasia Malek, MD, Ph.d.
Chief Scientific Officer, Medical Intelligence Unit
Dr. Malek is the head of scientific research for the Medical Intelligence Unit (MIU). In this capacity she manages a team of MIU analysts who are dedicated to research on behalf of Alivia’s clients who are diagnosed with different types of cancer.
Dr. Malek also serves as the Head of the Tumor Endocrinology Laboratory at the Petrov Institute in St. Petersburg, Russia, where her research focuses on RNA interference, miRNA biology and function, exosomes as a cancer diagnostics tool and mi/siRNA delivery systems.
She has published numerous original articles in peer reviewed international medical journals and scientific book chapters. Dr. Malek has conducted post graduate research at the Institute of Pathology, Charité, University of Medicine in Berlin, Germany and at the Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
She is also the co-founder and director of Oncosystem, a company that specializes in cancer diagnostic systems on the basis of exosomal miRNA analysis.
Dr. Malek graduated from the St. Petersburg State Medical University, Russia. She speaks Russian, English, German and Italian.
Michaela Hull, RNG
Senior Personal Health Manager, Medical Intelligence Unit
As Alivia’s Senior Personal Health Manager, Michaela plays a key role in execution of the company’s operations and service delivery. She manages a team of Personal Health Managers who are responsible for managing all aspects of our clients’ care, including liaising between Alivia’s clients and our medical team.
Michaela worked for more than 15 years as a practice manager and nurse for several private clinics, primarily within the cosmetic and aesthetic industry, as well as a nurse in the NHS.
Michaela is a registered nurse and received a Bsc (Hons) in Midwifery from The University of West London (f/k/a Thames Valley University). She is a member of the Royal College of Nursing and the British Association of Cosmetic Nurses.
Dr Elora Mukherjee, MBBS, MRCP, MSc, FHEA, Medical Intelligence Unit
Medical Director, UK
Dr Mukherjee is the Medical Director for Alivia in the UK, and oversees all medical team activities, including client cases. Dr Mukherjee also works as a consultant physician specialising in acute & general medicine and leads a team of doctors and nurses at a busy hospital in west London.
Dr Mukherjee has published widely within medicine. She has authored a medical text book, numerous book chapters and published articles in high impact journals such as The Lancet and the British Medical Journal. Dr Mukherjee is also a medical advisor and editor for the BMJ Learning Group, where she is able to use her skills in medical education.
Dr Mukherjee has received her primary medical degree from Karnataka Medical College, India, and post graduate degrees from University College London, The Royal College of Physicians and Loughborough Business School. She speaks English, Bengali and Hindi.
Dr Mukherjee is fully registered with the UK General Medical Council, registration number 5209540.